Anzeige
Mehr »
Login
Freitag, 27.09.2024 Börsentäglich über 12.000 News von 691 internationalen Medien
Jetzt ist die Zeit, um in unterbewertete Goldaktien mit MEGA-Hebel zu investieren!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
301 Leser
Artikel bewerten:
(1)

Ambulatory EHR Market worth $7.7 billion by 2027 - Exclusive Report by MarketsandMarkets

CHICAGO, June 16, 2022 /PRNewswire/ -- According to the new market research report "Ambulatory EHR Market by Delivery Mode (Cloud-based, On-premise), Application (e-Prescribing, PHM, Health Analytics, Practice, Patient & Referral Management), Practice Size (Large, Small-to-Medium, Solo), End User (Independent) - Global Forecast to 2027", published by MarketsandMarkets, the global market is projected to reach USD USD 7.7 billion by 2027 from an estimated USD 5.7 billion in 2022, at a CAGR of 6.1% during the forecast period.

MarketsandMarkets Logo

Browse in-depth TOC on "Ambulatory EHR Market"

142 - Tables
37 - Figures
193 - Pages

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=235617627

The Growth in this market is driven by the growing demand for HCIT solutions, the rising number of outpatient facilities, rising funding initiatives for improving the adoption of EHR. However, the high infrastructure costs, High cost of maintenance, and the unwillingness to adopt ambulatory EHR solutions in developing countries are expected to restrain market growth to a certain extent.

By delivery mode, the cloud-based segment accounted for the largest share of the ambulatory EHR market in 2021.

The cloud-based segment is estimated to have the largest share by delivery mode of the ambulatory EHR market.The large share of the segment is attributed to the increasing demand for cloud-based HCIT solutions, shift towards patient-centric healthcare delivery.

The health analytics segment is expected to witness the highest growth rate in the ambulatory EHR market, by application

Based on application, the orthopedic surgery segment is expected to register the highest CAGR during the forecast period. Factors responsible for the growth of this segment are the benefits offered by health analytics such as improved patient safety and health outcomes, evidence-based improvements in the quality of care, effective and efficient healthcare services, and forecasts of healthcare needs.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=235617627

North America dominated the ambulatory EHR market in 2021

North America accounted for the largest share of the market in 2021, followed by Europe and Asia Pacific. The large share of North America in the global market can be attributed to the presence of a strong IT infrastructure in the region, the large number of COVID-19 patients, increasing investments and regulatory mandates favoring the implementation of EHR solutions, and the rising utilization of remote patient monitoring solutions and services for the management of chronic diseases and lifestyle disorders. The presence of major market players in the US and a large number of outpatient healthcare facilities are further contributing to the growth of the market in the region.

Epic Systems Corporation (US), Cerner Corporation (US), Allscripts Healthcare Solutions, Inc. (US), Medical Information Technology, Inc. (MEDITECH, US), Computer Programs and Systems, Inc. (CPSI, US), are the major players in this market. These companies are majorly focusing on the strategies such as agreements, collaborations, partnerships, and service launches in order to remain competitive and further increase their share in the ambulatory EHR market.

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=235617627

Browse Adjacent Markets: Healthcare IT Market Research Reports & Consulting

Browse Related Reports:

Healthcare IT Market by Products & Services (Healthcare Provider Solutions, Healthcare Payer Solutions, & HCIT Outsourcing Services), Components (Services, Software,Hardware), End-User, and Region (2022 - 2026)

https://www.marketsandmarkets.com/Market-Reports/healthcare-it-252.html

Population Health Management Market by Component (Software, Services), Mode of Delivery (On-premise, Cloud-based), End User (Healthcare Providers, Healthcare Payers, Employer Groups, Government Bodies) - Global Forecasts (2022 - 2026)

https://www.marketsandmarkets.com/Market-Reports/population-health-management-market-263411936.html

About MarketsandMarkets

MarketsandMarkets provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:

Mr. Aashish Mehra
MarketsandMarkets INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/ambulatory-ehr-market.asp
Visit Our Web Site: https://www.marketsandmarkets.com
Content Source: https://www.marketsandmarkets.com/PressReleases/ambulatory-ehr.asp

Logo: https://mma.prnewswire.com/media/660509/MarketsandMarkets_Logo.jpg

© 2022 PR Newswire
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.